Aristo Pharma Nordic ApS — Credit Rating and Financial Key Figures

Aristo Pharma Nordic ApS (CVR number: 32328768) is a company from BALLERUP. The company reported a net sales of 0.5 mEUR in 2024, demonstrating a decline of -2.5 % compared to the previous year. The operating profit percentage was at 5.7 % (EBIT: 0 mEUR), while net earnings were 25.2 kEUR. The profitability of the company measured by Return on Assets (ROA) was 1.5 %, which can be considered weak but Return on Equity (ROE) was 16.7 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 6.6 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. Aristo Pharma Nordic ApS's liquidity measured by quick ratio was 35.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.